131 related articles for article (PubMed ID: 25587694)
1. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic effects on auditory sensory gating in schizophrenia patients.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
[TBL] [Abstract][Full Text] [Related]
4. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory?
Micoulaud-Franchi JA; Hetrick WP; Aramaki M; Bolbecker A; Boyer L; Ystad S; Kronland-Martinet R; Richieri R; Faget C; Faugere M; El-Kaim A; Cermolacce M; Lancon C; Vion-Dury J
Schizophr Res; 2014 Aug; 157(1-3):157-62. PubMed ID: 24893905
[TBL] [Abstract][Full Text] [Related]
5. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
[TBL] [Abstract][Full Text] [Related]
6. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
7. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
8. The effects of clozapine on cognitive functioning in schizophrenia.
McGurk SR
J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
[TBL] [Abstract][Full Text] [Related]
9. Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol.
Nagamoto HT; Adler LE; McRae KA; Huettl P; Cawthra E; Gerhardt G; Hea R; Griffith J
Neuropsychobiology; 1999; 39(1):10-7. PubMed ID: 9892854
[TBL] [Abstract][Full Text] [Related]
10. P50 gating in deficit and nondeficit schizophrenia.
Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
[TBL] [Abstract][Full Text] [Related]
11. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
[TBL] [Abstract][Full Text] [Related]
12. Sensory gating deficits and impaired quality of life in patients with schizophrenia: A preliminary study.
Micoulaud-Franchi JA; Faugere M; Boyer L; Cermolacce M; Fond G; Richieri R; Vion-Dury J; Lancon C
Psychiatr Danub; 2016 Sep; 28(3):225-233. PubMed ID: 27658831
[TBL] [Abstract][Full Text] [Related]
13. Effects of clozapine on cognitive function in schizophrenia.
Lee MA; Thompson PA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
[TBL] [Abstract][Full Text] [Related]
14. Normalization of information processing deficits in schizophrenia with clozapine.
Kumari V; Soni W; Sharma T
Am J Psychiatry; 1999 Jul; 156(7):1046-51. PubMed ID: 10401450
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
[TBL] [Abstract][Full Text] [Related]
16. Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia.
Micoulaud-Franchi JA; Faugere M; Boyer L; Cermolacce M; Richieri R; Faget C; Philip P; Vion-Dury J; Lancon C
Psychoneuroendocrinology; 2015 Jul; 57():125-33. PubMed ID: 25917886
[TBL] [Abstract][Full Text] [Related]
17. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
Kelemen O; Kiss I; Benedek G; Kéri S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
[TBL] [Abstract][Full Text] [Related]
18. Effects of sertindole on cognition in clozapine-treated schizophrenia patients.
Nielsen RE; Levander S; Thode D; Nielsen J
Acta Psychiatr Scand; 2012 Jul; 126(1):31-9. PubMed ID: 22356584
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
20. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients.
Chen XS; Li CB; Smith RC; Xiao ZP; Wang JJ
Psychiatry Res; 2011 Aug; 188(3):327-33. PubMed ID: 21216472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
